脓毒性休克中改善微循环治疗的研究进展  

Progress on improving microcirculation treatment in septic shock

作　　者：邱婷婷[1] 钱何布 刘军[2] QIU Tingting;QIAN Hebu;LIU Jun(Department of Critical Care Medicine,Suzhou Ninth Hospital affiliated to Soochow University,Suzhou Jiangsu 215200,China)

机构地区：[1]苏州大学附属苏州九院重症医学科,江苏苏州215200 [2]南京医科大学附属苏州医院重症医学科,江苏苏州215200

出　　处：《中国急救复苏与灾害医学杂志》2024年第12期1664-1667,共4页China Journal of Emergency Resuscitation and Disaster Medicine

基　　金：江苏省科技项目(编号:BE2021660)。

摘　　要：脓毒性休克是重症患者死亡的主要原因,微循环障碍贯穿于脓毒性休克发生、发展的各个阶段。既往研究表明早期纠正微循环障碍,可以显著改善脓毒性休克患者的预后,因此改善微循环是脓毒性休克治疗的关键环节。本文就改善脓毒性休克患者微循环的相关研究进行综述。Sepsis is the main cause of death in Critically ill Patients.Microcirculation dysfunction runs through every stage of the occurrence and development of sepsis.Studies have shown that early correction of microcirculation dysfunction can notably enhance the prognosis of sepsis patients,so improving microcirculation is a key step in the treatment of sepsis.This article reviews the research on improving microcirculation in sepsis patients.

关 键 词：脓毒性休克 微循环障碍 血管内皮细胞功能障碍 血管低反应性 治疗 

分 类 号：R631.4[医药卫生—外科学]